Merck, 92030604-1VL, 357-167-24

Immunogen
Highly purified recombinant human tumour necrosis factor alpha
Application
Not specified
Biochem/physiol Actions
Not specified
This weakly neutralising antibody is directed against human TNF alpha. It shows no cross-reactivity with human TNF alpha or β of most other species except simian TNF alpha.
Preparation Note
Maintain cultures between 3-9 x 100,000 cells/ml; 5% CO₂; 37 °C.
RPMI 1640 + 2 mM glutamine + 10% Fetal Bovine Serum (FBS) (heat inactivated)
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). Use of this product by any organization may require a license agreement. Customers will be contacted by [email protected] to provide further information after the order request is submitted. Any other use of these products is prohibited without the express written permission of UKHSA.
This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). Use of this product by commercial organizations may require a license agreement. Commercial customers will be contacted by [email protected] to provide further information after the order request is submitted. Any other use of these products is prohibited without the express written permission of UKHSA. Inquiries regarding authorized use of this cell line or its genomic DNA may be directed to [email protected].
Disclaimer
This cell line has special release conditions: All customers are required to complete a Cell line Release Authorisation form.